Edesa Biotech Inc reports results for the quarter ended in March - Earnings Summary

Edesa Biotech

12/05/2023 01:09

* Edesa Biotech Inc  EDSA.OQ  reported a quarterly adjusted
loss
of 12 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 17 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Edesa Biotech Inc's reported EPS for the quarter was a
loss
of 12 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Edesa Biotech Inc shares had risen by 8.5% this
quarter and
lost 54.2% so far this year.
    * The company reported a quarterly loss of $2.33 million.
    * Wall Street's median 12-month price target for Edesa
Biotech Inc
is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
12 at 12:09 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.17          -0.12          Beat
 Dec. 31 2022      -0.19          -0.13          Beat
 Sep. 30 2022      -0.39          -0.02          Beat
 Jun. 30 2022      -0.43          -0.37          Beat